Endurant Capital Management’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,844
Closed -$3.58M 68
2021
Q2
$3.58M Buy
5,844
+1,249
+27% +$815K 0.98% 39
2021
Q1
$3.22M Buy
4,595
+3,326
+262% +$2.39M 0.84% 39
2020
Q4
$955K Buy
+1,269
New +$887K 0.34% 48

Other funds holding MDVL

Endurant Capital Management's MDVL Position: Q3 2021 in Review

Endurant Capital Management sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2021, closing a stake of 5,844 shares — an estimated $3.58M sold.

Endurant Capital Management first reported a position in MDVL in Q4 2020 and held it in 3 quarters. The position peaked at $3.58M in Q2 2021. 49 funds tracked by Wall St. Rank hold MDVL as of Q3 2021.

  • Endurant Capital Management reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Endurant Capital Management sold 5,844 MedAvail Holdings, Inc. Common Stock shares in Q3 2021, an estimated $3.58M.
  • Endurant Capital Management first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Endurant Capital Management's MedAvail Holdings, Inc. Common Stock position peaked at $3.58M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2021.

Based on Endurant Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.